Click Here to return To Results

 

Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII? Stroke 40:833-840, Mayer,S.A.,et al, 2009 See this aricle in Pubmed Article Abstract A prospective trial would be needed to determine whether younger patients with ICH without extensive bleeding at baseline can benefit from 80 ?g/kg of rFVLLa given within 2.5 hrs of symptom onset.

Related Tags

(click to filter results - removes previous filter) cerebrovascular accident,young adult FAST trial hemostatic therapy intracerebral hemorrhage recombinant activated factor VII treatment of neurologic disorder

Click Here to return To Results